A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes…

Overview of attention for article published in European Heart Journal, August 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

blogs: 1 blog
twitter: 3 X users

patent: 15 patents
wikipedia: 1 Wikipedia page

Readers on

mendeley: 91 Mendeley

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 25,119 followers.

REG1 anticoagulation/reversal system in cardiac catheterization for ACS. Phase II RADAR trial. Eur. Heart J. (£) http://t.co/gno3SRPORz

RADAR Trial Results: EHJ http://t.co/MAtQhSuVIm @ACRRM @RuralDoctorsAus #RMA2013

A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safet... http://t.co/3Q3itgGGPc #cardiology

Novel anticoagulation and reversal system safe in catheterization for ACS—phase II RADAR trial in Eur. Heart J. ($) http://t.co/S2Zukl8B

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.